Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 287.50 GBp
Change Today +2.50 / 0.88%
Volume 15.0K
IDH On Other Exchanges
As of 11:47 AM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

immunodiagnostic systems hld (IDH) Snapshot

287.50 GBp
Previous Close
285.00 GBp
Day High
287.50 GBp
Day Low
287.50 GBp
52 Week High
10/9/14 - 342.50 GBp
52 Week Low
05/29/15 - 267.50 GBp
Market Cap
Average Volume 10 Days
0.08 GBp
Shares Outstanding
3.33 GBp
Dividend Yield

Related News

No related news articles were found.

immunodiagnostic systems hld (IDH) Related Businessweek News

No Related Businessweek News Found

immunodiagnostic systems hld (IDH) Details

Immunodiagnostic Systems Holdings PLC develops, manufactures, and markets immunoassays and automated immunoanalyser technologies for use in clinical and research laboratories worldwide. The company offers IDS-iSYS multi-discipline automated systems and manual assays for use in clinical areas, such as bone and calcium metabolism, chronic kidney disease and mineral bone disorders, fertility, growth disorders, and hypertension; and for use in animal research, bone turnover markers, cartilage markers, and other research areas. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.

346 Employees
Last Reported Date: 06/29/15
Founded in 1977

immunodiagnostic systems hld (IDH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

immunodiagnostic systems hld (IDH) Key Developments

Immunodiagnostic Systems Holdings plc Proposes Final Dividend for the Financial Year Ended 31 March 2015, Payable on August 21, 2015

Immunodiagnostic Systems Holdings plc announced that at the annual general meeting to be held on August 4, 2015, will propose the dividend of 3 pence per ordinary share of 2 pence in the capital of the company, to be paid on August 21, 2015 to shareholders whose names appear on the register of members in respect of such shares at the close of business on July 24, 2015.

Immunodiagnostic Systems Holdings plc Confirms Resignation of Chris Yates as CFO

Immunodiagnostic Systems Holdings plc confirmed that Chris Yates, CFO, who resigned on 4 December 2014, is leaving the group on June 29, 2015 following the end of his notice period.

Immunodiagnostic Systems Holdings plc Reports Audited Consolidated Earnings Results for the Year Ended March 31, 2015; Proposes Dividend for the Year Ended March 31, 2015, Payable on August 21, 2015

Immunodiagnostic Systems Holdings plc reported audited consolidated earnings results for the year ended March 31, 2015. For the year, the company reported revenue of GBP 45,362,000 compared to GBP 52,263,000 a year ago. Profit from operations was GBP 3,953,000 compared to GBP 8,258,000 a year ago. Profit before tax was GBP 4,053,000 compared to GBP 8,335,000 a year ago. Profit for the year attributable to owners of the parent was GBP 2,352,000 or 8.0 pence diluted per share compared to GBP 6,953,000 or 23.7 pence diluted per share a year ago. Adjusted diluted EPS was 11.0 pence compared to 28.4 pence a year ago. Net cash from operating activities was GBP 9,468,000 compared to GBP 12,289,000 a year ago. Purchases of other intangible assets were GBP 3,587,000 compared to GBP 3,698,000 a year ago. Purchases of property, plant and equipment were GBP 2,872,000 compared to GBP 2,226,000 a year ago. Profit on ordinary activities after tax as adjusted was GBP 3,226,000 compared to GBP 8,304,000 a year ago. Adjusted EBIT was GBP 4.9 million compared to GBP 10.1 million a year ago, before exceptional items. Statutory EBIT was GBP 4.0 million compared to GBP 8.3 million a year ago. The board of company proposed a dividend for the year of 3.0 pence against of 8.5 pence in 2014, subject to the approval of shareholders at the Annual General Meeting on August 04, 2015. If approved, the dividend will be paid on August 21, 2015 to shareholders on the register at the close of business on July 24, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDH:LN 287.50 GBp +2.50

IDH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IDH.
View Industry Companies

Industry Analysis


Industry Average

Valuation IDH Industry Range
Price/Earnings 37.2x
Price/Sales 1.9x
Price/Book 1.1x
Price/Cash Flow 15.5x
TEV/Sales 1.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNODIAGNOSTIC SYSTEMS HLD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at